Military spouse and nurse here, been through this with both my husband (active duty) and my father-in-law (retired). The Tricare GLP-1 situation as of early 2026:
What's on the Tricare formulary:
- Ozempic (semaglutide for T2D) — Tier 2, covered with PA. Copay: $0 at MTF pharmacy, $14 at retail network pharmacy on Tricare Prime, $28 on Tricare Select.
- Mounjaro (tirzepatide for T2D) — Tier 3, covered with PA. Similar copays.
- Wegovy (semaglutide for weight management) — this is the problem child. It's on the Uniform Formulary but classified as a "non-covered benefit" when prescribed solely for obesity. Covered only with T2D diagnosis.
- Zepbound — same as Wegovy, non-covered for weight management.
The workaround: if you have prediabetes with A1C ≥ 5.7, many Tricare PCMs will prescribe Ozempic off-label for "glucose management with weight reduction as secondary benefit." Express Scripts has been approving these PAs pretty consistently.